Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3439
+0.0139 (4.21%)
At close: Sep 4, 2026, 4:00 PM EDT
0.3548
+0.0109 (3.17%)
After-hours: Sep 4, 2026, 7:38 PM EDT
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of $65.29 million as of September 4, 2026. Its market cap has decreased by -67.98% in one year.
Market Cap
65.29M
Enterprise Value
170.98M
1-Year Change
-67.98%
Ranking
Category
Stock Price
$0.34
ChartMarket Cap Chart
Since December 1, 1998, Heron Therapeutics's market cap has decreased from $127.40M to $65.29M, a decrease of -48.75%. That is a compound annual growth rate of -2.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 65.30M | -72.61% |
| Dec 31, 2025 | 238.40M | 2.45% |
| Dec 31, 2024 | 232.70M | -8.78% |
| Dec 29, 2023 | 255.10M | -14.17% |
| Dec 30, 2022 | 297.20M | -68.07% |
| Dec 31, 2021 | 930.70M | -51.60% |
| Dec 31, 2020 | 1.92B | -9.13% |
| Dec 31, 2019 | 2.12B | 4.57% |
| Dec 31, 2018 | 2.02B | 105.15% |
| Dec 29, 2017 | 986.50M | 92.15% |
| Dec 30, 2016 | 513.40M | -46.54% |
| Dec 31, 2015 | 960.40M | 227.11% |
| Dec 31, 2014 | 293.60M | 110.32% |
| Dec 31, 2013 | 139.60M | -15.24% |
| Dec 31, 2012 | 164.70M | 258.04% |
| Dec 30, 2011 | 46.00M | 154.14% |
| Dec 31, 2010 | 18.10M | -63.51% |
| Dec 31, 2009 | 49.60M | 281.54% |
| Dec 31, 2008 | 13.00M | -73.25% |
| Dec 31, 2007 | 48.60M | 39.66% |
| Dec 29, 2006 | 34.80M | -10.08% |
| Dec 30, 2005 | 38.70M | -6.30% |
| Dec 31, 2004 | 41.30M | -18.22% |
| Dec 31, 2003 | 50.50M | 146.34% |
| Dec 31, 2002 | 20.50M | -63.91% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 69.34M |
| INmune Bio | 67.72M |
| XBiotech | 67.07M |
| BioStem Technologies | 66.22M |
| Boundless Bio | 65.28M |
| Edesa Biotech | 63.91M |
| eXoZymes | 63.58M |
| Elicio Therapeutics | 63.34M |